Cellular and molecular effects of growth hormone and estrogen on human bone cells

APMIS, Supplement

Volumn 105, Issue 71, 1997, Pages 7-30

  Kassem, Moustapha ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ESTROGEN; GROWTH HORMONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

BONE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; HORMONE ACTION; HUMAN; OSTEOBLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; STEM CELL; BIOLOGICAL MODEL; BONE; CELL CULTURE; CELL DIVISION; CYTOLOGY; DRUG EFFECT; FEMALE; METABOLISM; OSTEOCLAST; PHYSIOLOGY;

BONE AND BONES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CYTOKINES; ESTROGENS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MODELS, BIOLOGICAL; OSTEOBLASTS; OSTEOCLASTS; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0030625734     PISSN: 0903465X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0463.1997.tb05601.x     Document Type: Review

References (137)

1. Frost HM (1985): The skeletal intermediary organization: A synthesis. In: Bone and Mineral Research/3, WA Peck, ed. Elsevier Science Publishers, Amsterdam, pp. 49-107.
2. Parfitt AM (1988): Bone remodeling: Relationship to the amount and structure of bone, and the pathogenesis and prevention of fractures. In: Osteoporosis: Etiology, Diagnosis, and Management, BL Riggs, LJ Melton, eds. Raven Press, New York, pp. 45-93.
3. Eriksen EF (1986): Normal and pathological remodeling of human trabecular bone: Three dimensional reconstruction of the remodeling sequence in normal and in metabolic bone disease. Endocr Rev 7:379-408.
4. Fell HB, Robinson R (1929): The growth, development and phosphatase activity of embryonic avian femora and limb-buds cultivated in vitro. Biochem J 23:767-784.
5. Peck WA, Birge SJ, Fedak SA (1964): Bone cells: Biochemical and biological studies after enzymatic isolation. Science 146:1476-1477.
6. Kassem M (1994): Human bone cell proliferation and differentiation: effects of growth hormone and sex steroids on osteoblasts in culture. Ph.D.thesis, University of Aarhus, Aarhus, Denmark.
7. 3 and glucocorticoids on the growth of rat and mouse osteoblast-like bone cells. Calcif Tissue Int 35:806-811.
8. Mohan S, Jennings JC, Linkhart TA, Baylink DJ (1988): Primary structure of human skeletal growth factor: homology with human insulin-like growth factor-II. Bioch Bioph Acta 966:44-55.
9. Rodan GA, Noda M (1991): Gene expression in osteoblastic cells. Cri Rev Euk Gen Exp 1:85-98.
10. Owen M (1985): Lineage of osteogenic cells and their relationship to the stromal system. In: Bone and Mineral Research/3, WA Peck, ed. Elsevier Science Publishers, Amsterdam, pp. 1-25.
11. Beresford JN, Gallagher JA, Gowen M, McGuire MKB, Poser J, Russell RGG (1983): Human bone cells in culture. A novel system for the investigation of bone cell metabolism. Clin Sci 64:38-39.
12. Auf'mkolk B, Hauschka OV, Schwartz ER (1985): Characterization of human bone cells in culture. CalcifTissue Int 37:228-235.
13. Wergedal JE, Baylink DJ (1984): Characterization of cells isolated and cultured from human bone. Proc Soc Exp Bio Med 176:60-69.
14. Robey PG,Termine JD (1985): Human bone cells in vitro. Calcif Tissue Int 37:453-460.
15. Kopp JB, Robey PG (1992): Sodium fluoride does not increase human bone cell proliferation or protein synthesis in vitro (letter to the Editor). Calcif Tissue Int 50:96-98.
16. Kassem M, Rungby J, Mosekilde L, Eriksen EF (1992): Ultrastructure of human osteoblasts and associated matrix in culture. APMIS 100:490-497.
17. Bonucci E (1984): The structural basis of calcification. In: Ultrastructure of the connective tissue matrix, A Ruggeri, PM Motta, eds. M. Nijhoff Publishers, Boston.
18. Termine JD (1990): Bone matrix proteins and the mineralization process. In: Primer on the metabolic bone diseases and disorder of mineral metabolism, MJ Favus, ed. ASBMR, Kelseyville, pp. 16-18.
19. Hewlett CR, Cave J.Williamson M, Farmer J, Ali SY, Owen ME, Phil D (1986): Mineralization in vitro cultures of rabbit marrow stromal cells. Clin Orthop Rel Res 213:251-263.
20. Maniatopoulos C, Sodek J, Melcher AH (1988): Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Research 254:317-330.
21. Kassem M, Risteli L, Mosekilde L, Meisen F, Eriksen EF (1991): Formation of osteoblast-like cells from human mononuclear bone marrow cultures. APMIS 99:269-274.
22. Cheng SL, Yang JW, Rifas L, Zhang SF, Avioli LV (1994): Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134:277-286.
23. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI (1992): Characterization of cells with osteogenic potential from human marrow. Bone 13:81-88.
24. Vilamitjane-Amedee J, Bareille R, Rouais F, Caplan AI, Harmand M-F (1993): Human bone marrow stromal cells express an osteoblastic phenotype in culture. In Vitro Cell Dev Bio 29A:699-707.
25. Rickard D, Kassem M, HefferanT, Sarkar G, Speisberg TC, Riggs BL (1996): Isolation and characterization of osteoblast precursor cells from human bone marrow. J . Bone Min Res 11:312-324.
26. Bennett JH, Joyner CJ, Triffitt JT, Owen ME (1991): Adipocytic cells cultured from marrow have osteogenic potential. J Cell Sci 99:131-139.
27. Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME (1992): Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102:341-351.
28. Simmons PJ, Torok-Storb B (1991): Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1:55-62.
29. Gronthos S, Graves SE, Ohta S, Simmons PJ (1994): The STRO-1 + fraction of adult human bone marrow contains the osteogenic precursors. Blood 12:4164-4173.
30. Long MW,Williams JL, Mann KG (1990): Expression of human bone-related proteins in the hematopoietic microenvironment. J Clin Invest 86:1387-1395.
31. Haynesworth SE, Baber MA, Caplan AI (1992): Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13:69-80.
32. Gerstenfeld LC, Chipman SD, Glowacki J, Lian JB (1987): Expression of differentiated function by mineralizing cultures of chicken osteoblasts. Develop Biol 122:49-60.
33. Owen TA, Aronow M, Shalhoub V, Barone LM.Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS (1990): Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
34. Bellows CG, Aubin JE (1989): Determination of the number of osteoprogenitors in isolated fetal rat calvarial cells in vitro. Develop Biol 13:8-13.
35. Bellows CG.Wang YH, Heersche JN, Aubin JE (1994): 1,25-dihydroxyvitamin D3 stimulates adipocytic differentiation in cultures of fetal rat calvarial cells: comparison with the effects of dexamethasone. Endocrinology ' 134:2221-2229.
36. Bellows CG, Aubin JE, Heersche JNM, Antosz ME (1986): Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif Tissue Int 38:143-154.
37. Speisberg TC, Harris SA, Riggs BL (1995): Immortalized osteoblast cell systems. Calcif Tissue Int 56(suppl 1):s18-s21.
38. Harris SA, Enger RJ, Riggs BL, Speisberg TC (1995): Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Min Res 10:178-186.
39. Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Speisberg TC (1995): Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 59:193-201.
40. Kassem M, Okazaki R, DeLeon D, Harris SA, Speisberg TC, Conover CA, Riggs BL (1996): Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4 in a human osteoblastic cell line with high levels of estrogen receptors. Proc Assoc Amer Phy 108:155-163.
41. Burger EH, NijweidePJ (1991): Cellular origin and theories of osteoclast differentiation. In: The osteoclast, BK Hall, ed. CRC press, Boca Raton, pp. 31-59.
42. Chambers TJ (1989): The origin of the osteoclast. In: Bone and Mineral Research/6, WA Peck, ed. Eisevier, Amsterdam, pp. 1-25.
43. Testa NG, Alien TD, Lajtha LG (1981): Generation of osteoclasts in vitro. J Cell Sci 47:127-137.
44. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T (1988): Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382.
45. 3 than adult long-term marrow cultures. J Bone Min Res 2:311-317.
46. MacDonald BR.Takahashi N, McManus LM, Holahan J, Mundy GR, Roodman GD (1987): Formation of multinucleated cells that respond to osteotropic hormones in long-tern human bone marrow cultures. Endocrinology 120:2326-2333.
47. Kassem M, Mosekilde Li, Rungby J, Mosekilde Le, Meisen F, Eriksen EF (1991): Formation of osteoclasts and osteoblast-like cells in long-term human bone marrow cultures. APMIS 99:262-268.
48. Kurihara N, Bertolini D, Suda T, AkiyamaY, Roodman GD (1990): InterIeukin-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release. J Immunol 144:426-430.
49. MacDonald BR, Mundy GR, Clark S.Wang EA, Kuehl TJ, Stanley ER, Roodman GD (1986): Effects of human recombinant CSF-GM and Highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures. J Bone Min Res 1:227-233.
50. Chenu C, Pfeilschifter J, Mundy GR, Roodman GD (1988): Transforming growth factor B inhibits formation of osteoclast-like cells in long-term human marrow cultures. Proc Natl Acad Sci, USA 85:5683-5687.
51. Flanagan AM, Horton MA, Dorey EL, Collins DA, Evely JM, Moseley JM, Firkin FC, Chambers TJ, Helfrich MH, Martin TJ (1992): An assessment of the ability of human bone marrow cultures to generate osteoclasts. Int J Exp Pathol 73:387-401.
52. 3 and inhibition by Indomethacin. Calcif Tissue Int 55(supplement 1): s40.
53. Langagergard U (1994): Osteoblast-osteoklast interaktioner. Undergraduate thesis (diplom opgave), Faculty of Medicine, University of Aarhus, Aarhus, Denmark.
54. Isaksson OG, Lindhal A, Nilsson A, Isgaard J (1987): . Mechanisms of the stimulatory effects of growth hormone on longitudinal bone growth. Endocr Rev 8: 426-438.
55. Brixen K, Nielsen HK, Mosekilde L, Flyvbjerg A (1990): A short course of recombinant human growth hormone treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Min Res 5:609-619.
56. Marcus R, Butterfeild G, Holloway L, Gilliland L, Baylink DJ, Hintz RL, Sherman BM (1990): Effects of short term administration of recombinant human growth hormone to elderly people. J Clin Endocrinol Metab 70:519-527.
57. Brixen K, Kassem M, Loft AG, Nielsen HK, Flyvbjerg A, Mosekilde L (1995): Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: A dose response study. J Bone Min Res 10:1865-1874.
58. Slootweg MC, Buul-Offers SC, Herrmann-Erlee MPM, Meer JM, Duursma SA (1988): Growth hormone is mitogenic for fetal mouse osteoblasts but nor for undifferentiated bone cells. Endocrinology 116:11-13.
59. Slootweg MC, Buul-Offers SC, Herrmann-Erlee MPM, Duursma SA (1988): Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture. Acta Endocrinol 118:294-300.
60. Maor G, Hochberg Z, Mark K, Heinegard D, Silbermann M (1989): Human growth hormone enhances chondrogenesis and osteogenesis in a tissue culture system of chondroprogenitor cells. Endocrinology 125:1239-1245.
61. Scheven BAA, Hamilton NJ, Fakkeldji TMV, Duursma SA (1991): Effects of recombinant human insulin-like growth factor I and II (IGF-I/-II) and growth hormone (GH) on the growth of normal adult human osteoblastlike cells and human osteogenic sarcoma cells. Growth Regulation 1:160-167.
62. 3 and activity on human osteoblast-like cells in short-term cultures. Bone 11:81-86.
63. Kassem M, Blum W, Risteli J, Mosekilde L, Eriksen EF (1993): Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int 52:222-226.
64. Kassem M, Mosekilde L, Eriksen EF (1994): Growth hormone stimulates proliferation of human marrow stromal osteoblast-like cells in vitro. Growth Regulation 4:131-135.
65. Ernst M, Froesch ER (1988): Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor 1. Biochem Biophys Res Commun 151:142-147.
66. Kanzaki S, Baxter RC, Knutsen R, Baylink DJ, Mohan S (1995): Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid labile subunit both under basal and regulated conditions. J Bone Min Res 10: 854-858.
67. Blum WF, Breier BH (1994): Radioimmunoassay for IGFs and IGFBPs. Growth Regulation 4(suppl 1):11-19.
68. Mohan S, Strong DD, Dequeker J,Van den Eyned R, Peeters J, Aerssens J, Baylink DJ (1991): Increased IGF-I and IGF-II in bone from patients with osteoarthritis. J Bone Min Res 6(supplement 1):s131.
69. Hassager C, Spencer EM, Fitzpatrick LA, Riggs BL, Conover CA (1992): Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific. J Clin Endocrinol Metab 75:228-233.
70. Barnard R, Ng KW, Martin TJ, Waters MJ (1991): Growth hormone (GH) receptors in clonal osteoblastlike cells mediate a mitogenic response to GH. Endocrinology 128:1459-1464.
71. Slootweg MC, Salles JP, Ohlsson C, De Vries C, Engelbercht M, Netelenbos JC (1996): Growth hormone binds to a single high affinity receptor site on mouse osteoblasts: modulation by retinoic acid and cell differentiation. J Endocrinol 150:465-472.
72. Nilsson A, Swolin D, Enerback S, Ohlsson C (1996): Expression of functional growth hormone receptors in cultured human osteoblast-Iike cells. J Clin Endocrinol Metab 80:3483-3488.
73. Slootweg MC, Vangenesen ST, Otte AP, Duursma SA, Kruijer W (1990): Activation of Mouse Osteoblast Growth Hormone Receptor: C-Fos Oncogene expression independent of Phosphoinositide Breakdown and Cyclic AMP. J Mol Endocrinol 4:265-274.
74. Salles JP, De Vries C, Netelenbos JC, Slootweg MC (1994): Dexamethasone increases and serum decreases growth hormone receptor binding to UMR-106.01 rat osteosarcoma cells. Endocrinology 134:1455-1459.
75. Baker AR, Hollingshead PG, Pitts-Meek S, Hansen S, Taylor R, Stewart TA (1992): Osteoblast-specific expression of growth hormone stimulates bone growth in transgenic mice. Mol Cell Biol 12:5541-5547.
76. Mohan S, Baylink DJ (1993): Characterization of the IGF regulatory system in bone. Adv Exp Med Biol 343:397-406.
77. Slootweg MC, Ohlsson C, Salles JP, De Vries C, Netelenbos JC (1995): Insulin-like growth factor binding protein-2 and -3 stimulates growth hormone receptor binding and mitogenesis in rat osteosarcoma cells. Endocrinology 136:4210-4217.
78. Parfitt AM (1979): Quantum concept of bone remodeling and turnover: Implications for the pathogenesis of osteoporosis. Calcif Tissue Int 28:1-5.
79. Rudman D, Kutner MH, Rogers CM, Lubin MF, Fleming A, Bain RP (1981): Impaired growth hormone secretion in adult population. J Clin Invest 67:1361-1364.
80. Florini JR, Prinz PN,Vitiello MV, Hintz RL (1985): Somatomedin-C levels in healthy young and old men:relationship to peak and 24-hour integrated levels of growth hormone. J Gerontol 40:2-7.
81. Rudman D (1985): Growth hormone, body composition, and aging. J Am Geriatr Soc 33:800-807.
82. Rico H, Del Rio A, VilaT, Patino R, Carrera F, Espinos D (1979): The role of growth hormone in the pathogenesis of postmenopausal osteoporosis. Arch Intern Med 139:1263-1265.
83. Dequeker J, Burssens A, Bouillon R (1982): Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis. Horm Res 16:353-356.
84. Wüster C, Koppler D, Muller C, Seibel H, Schmidt-Gayk H, BlumW, Felsenberg D, Ziegler R (1995): Normal GH, PICP and ICTP and decreased PTH-24 hour secretion in osteoporosis. J Bone Miner Res 10(supplement 1):s180.(Abstract)
85. Bennett A.Wahner H, Riggs BL, Hintz R (1984): Insulin-like growth factors I and II: aging and bone density in women. J Clin Endocrinol Metab 59:701-704.
86. Pun KK, Lau P, Wong FHW, Cheng CL, Pun WK, Chow SP, Leong JCY (1990): 25-hydroxycholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures. Bone 11:397-400.
87. Wüster C, Blum W, Schlemilch S, Ranke MB, Ziegler R (1993): Decreased serum levels of insulin-like growth factors and IGF binding protein 3 in osteoporosis. J Int Med 234:249-255.
88. Ljunghall S, Johansson AG, Burman P, Kampe O, Lindh E, Karlsson FA (1992): Low plasma levels of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis. J Int Med 232:59-64.
89. Reed BY, Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CY (1995): Serum IGF-I is low and correlated with osteoblastic surface in idiopathic osteoporosis. J Bone Min Res 10:1218-1224.
90. Mohan S, Baylink DJ (1995): Development of a simple valid method for the complete removal of insulin-like growth factor (IGF)-binding proteins from IGFs in human serum and other biological fluids: comparison with acid-ethanol treatment and C18 Sep-Pak separation. J Clin Endocrinol Metab 80:637-647.
91. Kassem M, Brixen K, BlumW, Mosekilde L, Eriksen EF (1994): No evidence for reduced spontaneous or growth hormone-stimulated insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 (IGFBP-3) in patients with postmenopausal osteoporosis. Eur J Endocrinol 131:150-155.
92. Kassem M, Brixen K, Blum W, Mosekilde L, Eriksen EF (1994): Normal osteoclastic and osteoblastic responses to exogenous growth hormone in patients with postmenopausal spinal osteoporosis. J Bone Min Res 9:1365-1370.
93. Marie PJ, Sabbagh A, Vernejoul MC, Lomri A (1989): Osteocalcin and Deoxyribonucleic acid synthesis in vitro and histomorphometric indices of bone formation in postmenopausal osteoporosis. J Clin Endocrinol Metab 69:272-279.
94. Lomri A, Marie PJ (1990): Bone cell responsiveness to transforming growth factor B, parathyroid hormone and prostaglandin E2 in normal and postmenopausal osteoporotic women. J Bone Min Res 5:1149-1155.
95. Kassem M, Brixen K, Mosekilde L, Eriksen EF (1994): Human marrow stromal osteoblast-like cells do not show reduced responsiveness to in vitro stimulation with growth hormone in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:1-6.
96. Ankersen L (1994): Aging of human trabecular osteoblasts: Cellular and macromolecular characteristics of normal and osteoporotic osteoblasts. M.Sc. thesis, Department of Chemistry, University of Aarhus, Aarhus, Denmark.
97. Turner RT, Riggs BL, SpelsbergTC (1994): Skeletal effects of estrogen. Endocri Rev 16:275-300.
98. Riggs BL, Melton III LJ (1992): The prevention and treatment of osteoporosis. N Engl J Med 327:620-627.
99. Eriksen EF, Colvard DS, Berg NJ, Graham ML, Mann KG, Speisberg C, Riggs BL (1988): Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241:84-86.
100. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Korc M, Greene GL, O'Malley BW, Haussler MR (1988): Estrogen binding, receptor mRNA and biologic response in osteoblast-like osteocarcoma cell. Science 241:81-84.
101. Keeling PE, Scott RE, Colvard DS, Han IK, Spelsberg TC, Riggs BL (1991): Lackof a Direct Effect of Estrogen on Proliferation and Differentiation of Normal Human Osteoblast-Like Cells. J Bone Miner Res 6:297-304.
102. Gray TK, Flynn TC, Gray KM, Nabell LM (1987): 17B-estradiol acts directly on the clonal osteoblastic cell line UMR106. Proc Natl Acad Sci USA 88:6267-6271.
103. Ernst M, Heath JK, Schmid C, Froesch RE, Rodan GA (1989): Evidence for a direct effect of estrogen on bone cells in vitro. J Steo Bio 34:279-284.
104. Scheven BA, Damen CA, Hamilton NJ,Verhaar HJ, Duursma SA (1992): Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro. Biochem Biophys Res Commun 186:54-60.
105. Oursler MJ, Pederson L, Fitzpatrick L, Riggs BL, Speisberg TC (1994): Human giant cell tumors of the bone (osteoclastomas) as estrogen target cells. Proc Natl Acad Sci USA 91:5227-5231.
106. Robinson JA, Riggs BL, Spelsberg TC, Oursler MJ (1996): Osteoclasts and transforming growth factor-B: estrogen-mediated isoform-specific regulation of production. Endocrinology 137:615-621.
107. Rodan GA, MartinTJ (1981): Role of osteoblasts in hormonal control of bone resorption - a hypothesis. Calcif Tissue Int 33:344-351.
108. Manolagas SC, Jilka RL (1995): Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305-311.
109. Reddy SV, Takahashi S, Dallas M,Williams RE, Neckers L, Roodman RD (1994): Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone. J Bone Min Res 9:753-757.
110. Girasole G, Jilka RL, Passen G, Boswell S, Boder G, Williams DC, Manolagas SC (1992): 17β-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 89:883-891.
111. Pottratz S, BellidoT, Mocharia H, Crabb DS, Manolagas SC (1994): 17β-estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 9389:944-950.
112. Rickard D, Russell G, Gowen M (1992): Oestradiol inhibits the release of tumour necrosis factor but not interleukin 6 from adult human osteoblasts in vitro. Osteop Int 2:94-102.
113. Chaudhary LR, Spelsberg TC, Riggs BL (1992): Production of various cytokines by normal human osteoblast-like cells in response to interleukin-1 βand tumor necrosis factor-α: Lack of regulation by 17β-estradiol. Endocrinology 130:2528-2534.
114. Rifas L, Kenney JS, Marcelli M, Pacifici R, Cheng SL, Dawson LL, Avioli LV (1995): Production of interleukin-6 in human osteoblasts and human bone marrow stromal osteoprogenitor cells: Evidence that induction by interleukin-1 and tumor necrosis factor-ais not regulated by ovarian steroids. Endocrinology 136:4056-4067.
115. Gowen M (1994): Cytokine and cellular interactions in the control of bone remodelling. In: Bone and Mineral Research/8, JNM Heersche, JA Kanis, eds. Elsevier Science BV., Amsterdam, pp. 77-114.
116. Jilka RL, Hangoc G, Griasole G, Passen G, Williams DC, Abrams JS, Boyce B, Broxmeyer H, Manolagas SC (1992): Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257:88-91.
117. Passed G, Girasole G, Jilka RL, Manolagas SC (1993): Increased interleukin-6 production by murine bone marrow and bone cells after estrogen withdrawal. Endocrinology 133:822-828.
118. Kitazawa R, Kimble RB,Vannice JL, Kung VT, Pacifici R (1994): Interleukin-1 receptor antagonist and tumour necrosis factor binding protein decrease osteoclast formation and bone resorption in ovrectomized mice. J Clin Invest 94:2397-2406.
119. Miyaura C, Kusano K, Masuzawa T, Chaki O, Onoe Y, Aoyagi M, Sasaki T, Tamura T, Koishihara Y, Ohsugi Y, Suda T (1995): Endogenous bone-resorbing factors in estrogen deficiency: Cooperative effects of IL-1 and IL-6. J Bone Min Res 10:1365-1373.
120. Pacifia R, Rifas L, Mccracken R,Vered I, McMurtry C, Avioli LV, Peck WA (1989): Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release. Proc Natl Acad Sci USA 86:2398-2402.
121. Pacifici R, Brown C, Puscheck E, Friedrich E, Slatopolsky E, Maggio D, Mccracken R, Avioli LV (1991): Effect of surgical menopause and estrogen replacement on cytokine release from human blood mononuclear cells. Proc Natl Acad Sci USA 88:5134-5138.
122. Pioli G, Basini G, Pedrazzoni M, Musetti G, Ulietti V, Bresciani D, Villa P, Bacchi A, Hughes D, Russell RGG (1992): Spontaneous release of interleukin-1 and interleukin-6 by peripheral blood mononuclear cells after oophrectomy. Clin Sci 83:503-507.
123. Ralston SH (1994): Analysis of gene expression in human bone biopsies by polymerase chain reaction: evidence for enhanced cytokine expression in postmenopausal osteoporosis. J Bone Min Res 9:883-890.
124. Cohen-Solal ME, Graulet AM, Gueris DJ, Baylink D, Vernejoul MCDe (1993): Peripheral monocyte cultures supernatants of menopausal women can induce bone resorption:involvement of cytokines. J Clin Endocrinol Metab 77:1648-1653.
125. Hustmyer FG,Walker E, Xiao-peng Yu, Girasole G, Sakagami Y, Peacock M, Manolagas SC (1993): Cytokine production and surface antigen expression by peripheral blood mononuclear cells in postmenopausal osteoporosis. J Bone Min Res 8:51-59.
126. Pacifici R, Vannice JL, Rifas L, Kimble RB (1993): Monocytic secretion of interleukin-l receptor antago-nist in normal and osteoporotic women: effects of menopause and estrogen/progesterone therapy. J Clin Endocrinol Metab 77:1135-1141.
127. Bismar H, Diel I, Ziegler R, Pfeilschifter J (1996): Increased cytokine secretion by human bone marrow cells after menopause or discontinuation of estrogen replacement. J Clin Endocrinol Metab 80:3351-3355.
128. Khosla S, Peterson JM, Egan K, Jones JD, Riggs BL (1994): Circulating cytokine levels in osteoporotic and normal women. J Clin Endocrinol Metab 79:707-711.
129. McKane WR, Khosla S, Peterson JM, Egan K, Riggs BL (1994): Circulating levels of cytokines that modulate bone resorption: effects of age and menopause in women. J Bone Min Res 9:1313-1318.
130. Girasole G, Pedrazzoni M, Guiliani N, Passed G, Bacchi A, Sansoni P, Passeri M (1995): Increased levels of human serum soluble interleukin-6 reeptors in ovariectomized women: evidence of a relationship with parathyroid hormone and FSH. Bone 16(supplement 1):98s.(Abstract)
131. Kassem M, Harris SA, Speisberg TC, Riggs BL (1996): Estrogen inhibits interleukin-6 production and gene expression in a human osteoblastic cell line expressing high levels of estrogen receptors. J Bone Min Res 11:193-199.
132. Davis VL, Couse JF, Gray TK, Korach KS (1994): Correlation between low levels of estrogen receptors and estrogen responsivenss in two rat osteoblast-like cell lines. J Bone Min Res 9:983-991.
133. Kassem M, Khosla S, SpelsbergTC, Riggs BL (1996): Cytokine production in the bone marrow microenvironment: failure to demonstrate estrogen regulation in early postmenopausal women. J Clin Endocrinol Metab 81:513-518.
134. Pacifici R, Basilico C, Roman J, Zutter MM, Santoro SA, McCracken R (1992): Collagen-induced release of interleukin 1 from human blood mononuclear cells: potentiation by fibronectin binding to oc5β1 intergrin. J Clin Invest 61:67-75.
135. Oliver MH, Harrison NK, Bishop JE, Cole RI, Laurent GJ (1989): A rapid and convenient assay for counting cells cultured in microwell plates: Application for assessement of growth factors. J Cell Sci 92:513-518.
136. Kassem M, Conover CA, Okazaki R, SpelsbergTC, Riggs BL (1997): Estrogen increases mRNA of insulinlike growth factor I (IGF-I) but not IGF-II in a human osteoblastic cell line with high levels of estrogen receptors. Calcif Tissne Int (in press).
137. BlumWF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ, Bierich JR (1990): A specific radioimmunoassay for the growth hormone(GH)-dependent somatomedinbinding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab 70:1292-1298.